Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07275424 · ClinicalTrials.gov registry record · Phase 2
Study of Healthy Aging and Physical Function With Elamipretide
A Phase 2 study of Aging, Healthy, sponsored by David Marcinek.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07275424: Recruiting Phase 2 study of Aging, Healthy, sponsored by David Marcinek.
NCT07275424 is a Phase 2 study of Aging, Healthy that is actively recruiting participants, run by David Marcinek. The registered enrollment target is 30 participants, below the 55-participant average among 4 other Aging, Healthy trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07275424, a Phase 2 study of Aging, Healthy, is actively recruiting participants, sponsored by David Marcinek.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will utilize a daily dose of elamipetide for 4 weeks and will screen a sufficient number of subjects for 30 subjects to enroll in the study. The planned duration of the study includes baseline measurement, followed by 4 weeks intervention period, a midpoint (2week ±3days) check-in phone interview, and post intervention visits that mirror the baseline visits. After the last injection, subjects will enter the 2-week follow-up period, concluded by the end-of-study contact.
Conditions Studied
Interventions
- DRUG Elamipretide will be supplied as a sterile 5.0 mL single-patient, multi-dose glass vial containing 3.75 mL of elamipretide solution (elamipretide [80 mg/mL], phosphate buffer, and benzyl alcohol)
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-11-26 |
| Est. Completion | 2026-04-15 |
| Phase | Phase 2 |
What NCT07275424 shows while recruiting
NCT07275424 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 55-participant average among 4 other Aging, Healthy trials with a reported enrollment target (45% lower).
The record links to 1 condition, with Aging, Healthy appearing as the primary indexed condition, and to 1 intervention - of which Elamipretide will be supplied as a sterile 5.0 mL single-patient, multi-dose glass vial containing 3.75 mL of elamipretide solution (elamipretide [80 mg/mL], phosphate buffer, and benzyl alcohol) is the first listed.
NCT07275424 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT07275424 about?
NCT07275424 is a clinical study titled "Study of Healthy Aging and Physical Function With Elamipretide". This study will utilize a daily dose of elamipetide for 4 weeks and will screen a sufficient number of subjects for 30 subjects to enroll in the study. The planned duration of the study includes baseline measurement, followed by 4 weeks intervention period, a midpoint (2week ±3days) check-in phone i...
What is the current status of trial NCT07275424?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2025-11-26. Estimated completion is 2026-04-15.
What conditions does trial NCT07275424 study?
This clinical trial studies the following conditions: Aging, Healthy.
What interventions are being tested in trial NCT07275424?
The interventions under investigation include: Elamipretide will be supplied as a sterile 5.0 mL single-patient, multi-dose glass vial containing 3.75 mL of elamipretide solution (elamipretide [80 mg/mL], phosphate buffer, and benzyl alcohol) (DRUG).
Who is sponsoring clinical trial NCT07275424?
This trial is sponsored by David Marcinek, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07275424 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging, Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Emotional Well-being and Measures of Healthy Aging
RECRUITING · NA
-
Physical and Cognitive Aging Study in Older Adults
RECRUITING
-
Personalized Approach to Promote Healthy Aging
ACTIVE NOT RECRUITING · NA
-
Circadian Health Regulation and Optimization for Rejuvenation Outcomes
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI